Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation
出版年份 2023 全文链接
标题
Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2023-10-20
DOI
10.1093/jac/dkad328
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses
- (2023) Lucas Perez et al. Journal of Fungi
- Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects
- (2022) Shinichiro Shirae et al. Clinical Pharmacology in Drug Development
- Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support
- (2022) Michelle Miller et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis
- (2022) Rainer Höhl et al. MYCOSES
- Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
- (2022) Lisa Kriegl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- COVID-19-associated fungal infections
- (2022) Martin Hoenigl et al. Nature Microbiology
- Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation—authors’ response
- (2022) Stefan Hatzl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
- (2022) Beatrijs Mertens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
- (2021) Matteo Bassetti et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation
- (2021) Ruth Van Daele et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
- (2021) Lore Vanderbeke et al. INTENSIVE CARE MEDICINE
- A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation
- (2021) Ruth Van Daele et al. Microorganisms
- Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice
- (2021) Dietmar Enko et al. Journal of Laboratory Physicians
- Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
- (2020) Christoph Zurl et al. Journal of Fungi
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
- (2019) E Furfaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories
- (2019) Federico Pea et al. THERAPEUTIC DRUG MONITORING
- The REDCap consortium: Building an international community of software platform partners
- (2019) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
- (2019) Oliver A. Cornely et al. MYCOSES
- Population Pharmacokinetics of Intravenous Isavuconazole in Solid Organ Transplant Recipients
- (2019) Xuemei Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
- (2018) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
- (2018) Alexander F A D Schauwvlieghe et al. Lancet Respiratory Medicine
- Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials
- (2018) David R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases
- (2018) Thomas Kaindl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection
- (2016) Francesco Barchiesi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent
- (2015) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
- (2012) Stijn I. Blot et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
- (2009) I. Spriet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation
- (2008) Stéphanie Ruiz et al. INTENSIVE CARE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started